Dr. Hui Yang, Founder and Chief Scientific Advisor of Huida Gene and National Science Fund for Distinguished Young Scholars Recipient, Confirmed to Speak at the 2023 Future Healthcare Technology Conference

The latest 2023 Nature Index rankings, released recently, show that China has surpassed the United States for the first time, underscoring the rapid advancement of China’s scientific research capabilities and foundational research strengths. Perhaps now, and in the near future, we should venture further into the vast, mysterious “uncharted territories,” positioning ourselves as explorers, questioners, and leaders.

The 2023 Future Healthcare Technology Conference will be held in Hefei from November 30 to December 1, 2023.The conference will systematically review the 30 most noteworthy frontier technologies in the life and health sector, inviting research scholars aligned with these technological trends to share insights on emerging technical directions. It aims to create a technological showcase featuring launches of cutting-edge technologies, displays of innovative tech products, and ecosystem collaborations among medical technology enterprises. Having been successfully held for three consecutive editions, this year’s conference is expected to attract over 100 influential figures in technology, 100 tech companies, and 800 professional attendees.

Yang Hui, Founder and Chief Scientific Advisor of Hui-Gene Therapeutics and Recipient of the National Science Fund for Distinguished Young Scholars, Confirmed to Attend the 2023 Future Medical Technology Conference, and will address"Gene Editing and Gene Therapy"Share insights on the topic.

Yang Hui, Principal Investigator at the Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences; Founder and Chief Scientific Advisor of Hui-Gene Therapeutics; recipient of the National Science Fund for Distinguished Young Scholars; Shanghai Top Young Talent and Outstanding Academic Leader; awardee of the Ho Leung Ho Lee Foundation Prize for Progress in Science and Technology, the Vcanbio Life Medicine Innovation Breakthrough Award, and the WuXi AppTec Life Chemistry Research Award for Outstanding Achievement.

Mr. Yang Hui has long been dedicated to research in the field of gene editing, achieving a series of original results in the development of gene editing technologies, safety evaluation, and clinical translation of gene therapies for hereditary diseases. He pioneered GOTI, a more sensitive technique for detecting off-target effects in gene editing, and provided the first evidence that single-base editing tools exhibit significant DNA and RNA off-target effects. He has developed various compact RNA and DNA editing tools with foundational patents, which have been granted authorization in both China and the United States. Additionally, he pioneered a glycosylase-mediated DNA single-base editing system that operates independently of deaminases. His research findings have been published in top international journals, including Science, Nature, Cell, Nature Methods, Nature Biotechnology, Nature Cell Biology, and Cell Research. Notably, his work titled “Single-Base Gene Editing Causes Extensive Off-Target Effects and Its Optimized Solutions” was selected as one of the “Top Ten Advances in Life Sciences in China 2019.”

Main Forum — Medical Technology Barometer Conference

Time: Nov 30–Dec 1 (2 days) 09:00–17:00

As the main forum of the 2023 Future Medical Technology Conference, the 2023 Future Medical Technology Trendsetter Summit will be divided into four sessions: the Opening Ceremony, Digital Technology, Biotechnology, and Intelligent Manufacturing. Focusing on 30 major frontier technology trends, the event will invite relevant government officials, academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, leading scholars in frontier technologies, corporate representatives, and renowned investors to participate.

Thematic Forum – Smart Medical Device Innovation Forum

Time: November 30, 13:30-17:00

Following the release of the 2019 Catalogue for Guiding Industrial Structure Adjustment, the development and application of high-end medical devices, such as AI-assisted medical equipment, have once again been included in the 2023 Encouraged Category. This signifies that the integrated innovation of digital technologies and medical devices has become a major trend in the healthcare industry. This forum specially invites research experts, entrepreneurs in the intelligent medical device sector, and investors to provide a comprehensive analysis of the development of intelligent medical devices from the perspectives of policy, upstream and downstream industry chains, and capital markets, and to jointly explore future trends and innovative pathways for intelligent medical devices.

Thematic Forum – Frontier Technology Innovation in Gene Sequencing Forum

Time: November 30, 13:30–17:00

Gene sequencing stands as one of the most prominent innovative technologies in cutting-edge science and clinical applications, representing a highly lucrative sector. In a remarkably short period, gene sequencing technology has fostered a vast industrial chain, with upstream segments comprising sequencers and consumables, midstream segments focused on sequencing and data services, and downstream segments dedicated to research and clinical applications. This forum will primarily explore advancements in frontier gene sequencing technologies and innovations in their applications.

Thematic Forum – Generative AI Scenario Innovation Application Forum

Time: December 1, 09:00-12:00

With the explosive growth and diversification of medical data, the application of artificial intelligence in the healthcare sector has become increasingly prevalent. Over the past year, generative AI, as the most creative and imaginative branch of artificial intelligence technologies, has firmly captured the attention of healthcare professionals. This forum will invite research experts, leading AI companies, and top-tier investors to provide an in-depth analysis of the latest developments and applications of generative AI, as well as its future opportunities.

2023 FTC 5th Frontier Technologies Forum in Cardiac Surgery

Time: December 1, 09:00-17:00

Co-hosted by the Cardiac Surgery Technology and Engineering Committee of the China Medical Biotechnology Association and Peking Union Medical College Hospital, and co-organized by VCBeat, the “2023 FTC 5th Forum on Frontier Technologies in Cardiac Surgery” aims to bring together experts, scholars, corporate representatives, and industry professionals from both domestic and international cardiac surgery fields to jointly discuss technological advancements and development trends, industrial innovation, and collaborative opportunities in cardiac surgery.

The 3rd Conference of the Innovation and Translation Branch of Neurosurgery, China Association of Health Care for the Elderly

Time: December 1, 09:00-17:00

Centered on the ITMNS Association’s clinical resources, the forum will synergize with innovation and translation resources—including regulatory review agencies, innovative enterprises, and financial capital—to create a platform for in-depth exchange and win-win collaboration among neurosurgery experts, scholars, entrepreneurs, and other stakeholders. Through activities such as white paper releases, awards for outstanding projects, and sharing of innovative practices, participants will discuss frontier trends and application cooperation in domestic neurosurgical translational research and industrial innovation.

For more details on conference speakers, seeCountdown to the Conference | First Batch of Speakers Announced for the 2023 Future Healthcare Technology Conference。